Wytwarzanie lub obrót dopalaczami jako czyn z art. 165 § 1 pkt 2 k.k. [PDF]
Acta Iuris Stetinensis, 2018 The article discusses the issues of possibility to qualify producing or marketing the designer drugs as an offence form article 165 § 1 point 2 cc. The analysis is subjected primarily to ratio legis of this regulation, which shows that it does not have ...
Magdalena Kowalewska-Łukuć
doaj +2 more sources
Identificação química da clorofenilpiperazina (CPP) em comprimidos apreendidos Chemical identification of chlorophenylpiperazine in seized tablets [PDF]
Química Nova, 2010 Designer drug is a term used to describe psychoactive drugs of abuse which are usually synthesized by modifying the molecular structures of existing drugs of abuse.
Rafael Lanaro +3 more
doaj +4 more sources
Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs [PDF]
Molecules, 2022 The ongoing development of more and more new psychoactive substances continues to be a huge problem in 2022 affecting the European and international drug market. Through slight alterations in the structure of illicit drugs, a way to circumvent the law is
Elisabeth Seibert +3 more
doaj +2 more sources
Emergency Physicians' Knowledge of Cannabinoid Designer Drugs [PDF]
Western Journal of Emergency Medicine, 2013 Introduction: The use of synthetic drugs of abuse in the United States has grown in the last few years, with little information available on how much physicians know about these drugs and how they are treating patients using them.
Patrick M Lank +2 more
doaj +2 more sources
Stimulation of the Epithelial Na+ Channel in Renal Principal Cells by Gs-Coupled Designer Receptors Exclusively Activated by Designer Drugs [PDF]
Frontiers in Physiology, 2021 The activity of the Epithelial Na+ Channel (ENaC) in renal principal cells (PC) fine-tunes sodium excretion and consequently, affects blood pressure.
Antonio G. Soares +7 more
doaj +2 more sources
Beyond THC: the new generation of cannabinoid designer drugs [PDF]
Frontiers in Behavioral Neuroscience, 2011 Synthetic cannabinoids are functionally similar to delta9-tetrahydrocannabinol (THC), the psychoactive principle of cannabis, and bind to the same cannabinoid receptors in the brain and peripheral organs.
Liana eFattore +3 more
doaj +2 more sources
Filter Feature Selection for Unsupervised Clustering of Designer Drugs Using DFT Simulated IR Spectra Data. [PDF]
ACS Omega, 2021 He K.
europepmc +3 more sources
Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs. [PDF]
J Cheminform, 2022 He K.
europepmc +3 more sources
Designer drugs and sexual dysfunction. [PDF]
Cent European J Urol, 2015 Benyó M.
europepmc +2 more sources